Intriguingly, recent preclinical evidence has also identified TAAR1 as a novel regulator of metabolic control and a potential target for obesity and type 2 diabetes [16,17,61,62]. Here, TAAR1 is linked to obesity due to melanocortin 4 receptor deficiency.